You have 9 free searches left this month | for more free features.

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

NGM Biopharmaceuticals, Inc (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

ngm707 (1)

ngm707 plus pembrolizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

ngm707

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting

Mesothelioma
+14 more

NGM707
NGM707 plus pembrolizumab

Los Angeles, California
+13 more

Aug 16, 2022